Kui Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kui Zhao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Bao Zhang
Department of Gastric Surgery, Dadong District, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, China
1 shared publicationFurong Zhong
State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publicationGuangqin An
State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publicationGuoliang Zheng
Department of Gastric Surgery, Dadong District, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, China
1 shared publicationHaiyue Yu
Department of Gastric Surgery, Dadong District, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, China
1 shared publicationJiahao Wang
State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 5 April 2025
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (2) , 1-22
Therapeutic applications and potential biological barriers of nano-delivery systems in common gastrointestinal disorders: a comprehensive review
- 5 April 2025
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (2) , 1-22
Top Cited PapersOpen AccessTherapeutic applications and potential biological barriers of nano-delivery systems in common gastrointestinal disorders: a comprehensive review
- Open Access
- 15 January 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 16 (1) , 100376
Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy
The onset and progression of type 2 diabetes mellitus (T2DM) are strongly associated with imbalances in gut bacteria, making the gut microbiome a new potential therapeutic focus. This commentary examines the recent publication in World Journal of Diabetes . The article explores the association between T2DM and gut microbiota, with a focus on the pathophysiological changes related to dysbiosis. It proposes innovative microbiome-targeted therapeutic strategies and evaluates the challenges and future directions of such approaches. This editorial summarizes the key points of their discussion of the role of the gut microbiome in T2DM and elaborates on the influence of specific gut microbial species on the disease through the host–microbiota metabolic axis. It provides new insights for future research on gut-microbiota-based interventions for T2DM.
- 15 January 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 16 (1) , 100376
Open AccessInfluence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy
The onset and progression of type 2 diabetes mellitus (T2DM) are strongly associated with imbalances in gut bacteria, making the gut microbiome a new potential therapeutic focus. This commentary examines the recent publication in World Journal of Diabetes . The article explores the association between T2DM and gut microbiota, with a focus on the pathophysiological changes related to dysbiosis. It proposes innovative microbiome-targeted therapeutic strategies and evaluates the challenges and future directions of such approaches. This editorial summarizes the key points of their discussion of the role of the gut microbiome in T2DM and elaborates on the influence of specific gut microbial species on the disease through the host–microbiota metabolic axis. It provides new insights for future research on gut-microbiota-based interventions for T2DM.